BOSTON – JLL Capital Markets has announced the closing of the $ 33 million sale of Sanofi Genzyme’s Northborough Global Operations Center, a 212,000 square foot, fully net-leased, GMP-certified industrial facility in the suburbs of Boston, in the community of Northborough, MA.
JLL represented the Buyer, a joint venture partnership between Wheelock Street Capital and Camber Development, which acquired the assets of Chicago-based Capri Egm. In addition, JLL was hired by the new owner to secure post-acquisition financing.
Sanofi Genzyme’s Northborough Global Operations Center is occupied by Sanofi Genzyme, a Cambridge, Massachusetts-based biotechnology company, under a long-term net lease, and the company uses the property as a conditioning, testing and of distribution. The building was completed in 1987 and includes cGMP warehouse space – which refers to current good manufacturing practice rules enforced by the FDA – for shipping and receiving, quality control and shelving storage. cold and at great height, as well as offices and a laboratory. .
The Sanofi Genzyme facility is located on 19.33 acres of land site at 11 Forbes …
Read Additional From Source
Copyright @ bostonrealestatetimes.com
News Highlights Science
- According to the source Sanofi Genzyme’s industrial and scientific life facility in Northborough trades for $ 33 million
- Check all news and articles from the Science news information updates.